Traits | Treatment | Chromosome | Peak position (bp) | Peak value | known loci |
---|---|---|---|---|---|
CD | CDAN2d | 1 | 9,773,247 | 5.3599 | qAGP1, Liu et al. (2021a) |
CDAN2d | 2 | 5,392,354 | 5.9180 | qAG2.1, Kim et al. (2019) | |
CDAN4d | 9 | 21,404,841 | 5.8758 | qCD-9-3, Yang et al. (2019) | |
CL | CLAN2d | 12 | 26,942,207 | 5.1454 | qCSA-12-2, Yang et al. (2019) |
CLAN2d | 3 | 32,459,894 | 5.4106 | S3_32459722, Su et al. (2021) | |
CLAN3d | 3 | 36,409,153 | 5.1926 | qSUR3-1Rc222-SCR-14, Ghosal et al. (2019) | |
CSA | CSAAN2d | 1 | 25,169,822 | 5.4387 | |
CSAAN3d | 2 | 26,714,756 | 6.5526 | ||
CV | CVAN2d | 1 | 31,418,900 | 6.7756 | qAG-1-2, Angaji et al. (2010); S1_31006962, Hsu and Tung (2015) |
CVAN2d | 1 | 38,223,398 | 8.6772 | qCLN1, Liu et al. (2021a) | |
CVAN2d | 1 | 38,596,277 | 5.6269 | qCD-1, Yang et al. (2019) | |
CVAN2d | 2 | 20,748,476 | 5.3130 | qGS2.1, Chen et al. (2012); qAG-2, Angaji et al. (2008); qAG-2-1, Angaji et al. (2010) | |
CVAN2d | 3 | 23,491,435 | 5.0665 | ||
CVAN2d | 6 | 9,925,796 | 11.7983 | qCSA-6 and qCV-6-1, Yang et al. (2019) | |
CVAN2d | 9 | 10,654,108 | 6.3812 | qAG9-3, Liu et al. (2021b) | |
CVAN2d | 11 | 3,769,274 | 10.0400 | qAG11, Jeong et al. (2020) | |
CVAN3d | 1 | 9,390,882 | 5.4285 | qAGP1, Liu et al. (2021a) | |
CVAN3d | 3 | 8,956,500 | 5.2753 | qAGP3, Liu et al. (2021a) | |
CVAN3d | 3 | 27,826,611 | 8.1694 | S3_27854371, Su et al. (2021) | |
CVAN3d | 3 | 28,227,524 | 7.0063 | S3_28290634, Su et al. (2021) | |
CVAN3d | 6 | 30,191,930 | 5.7992 | seq-rs3121, Zhang et al. (2017) | |
CVAN3d | 10 | 12,877,840 | 5.0584 | qAG10-1, Liu et al. (2021b) | |
CVAN4d | 1 | 9,494,163 | 5.1458 | qAGP1, Liu et al. (2021a) | |
CVAN4d | 1 | 26,025,387 | 5.9391 | qAG-1-2, Angaji et al. (2010) | |
CVAN4d | 7 | 4,973,098 | 5.2164 | seq-rs3210, Zhang et al. (2017) | |
CVAN4d | 8 | 24,896,504 | 5.5620 | seq-rs3972, Zhang et al. (2017) | |
CVAN4d | 12 | 21,775,097 | 5.8391 | qCL-12 and qCSA-12-1, Yang et al. (2019) |